Tirzepatide CAS: 2023788-19-2 Chaw tsim tshuaj paus

Tirzepatide tau tsim los ua tus agonist dual rau GLP-1 thiab gastric inhibitory polypeptide (GIP) receptors (Frias li al., 2018).Zoo ib yam li GLP-1, GIP yog ib qho tshuaj incretin uas ua haujlwm los tsim cov tshuaj insulin secretion.Tirzepatide yog nyob rau theem 3 kev loj hlob rau cov neeg laus uas muaj rog lossis rog rog nrog qhov hnyav txog kev sib txuam thiab tam sim no nyob rau hauv kev tswj xyuas raws li kev kho mob rau cov laus uas muaj ntshav qab zib hom 2. .Nws kuj tseem raug kawm raws li kev kho mob rau cov uas tsis yog-alcoholic steatohepatitis (NASH) thiab lub plawv tsis ua hauj lwm nrog khaws cia ejection feem (HFpEF).

Order los yog Thov Quote

Product Detail

Khoom cim npe

Kev siv thiab cuam tshuam

Tirzepatide yog siv nrog kev noj zaub mov kom zoo thiab kev tawm dag zog los tswj cov ntshav qab zib hauv cov neeg mob ntshav qab zib hom 2.Kev tswj cov ntshav qab zib siab pab tiv thaiv lub raum puas, qhov muag tsis pom, teeb meem paj hlwb, poob ntawm ceg tawv, thiab teeb meem kev sib deev.Tirzepatide muaj kev sib raug zoo rau GIP receptors ntau dua li GLP-1 receptors, thiab qhov kev coj tus cwj pwm agonist dual no tau pom tias yuav txo tau ntau dua. hyperglycemia piv rau kev xaiv GLP-1 receptor agonist.Cov kev tshawb fawb qhia tau pom tias qhov no yog vim tirzepatide ua raws li cov kev ua ntawm ntuj GIP ntawm GIP receptor.

Khoom qauv

Cov khoom ntim:

Cov ntaub ntawv ntxiv:

Kev sib xyaw	Na
Assay	99%
Qhov tshwm sim	Dawb hmoov
CAS Nr.	2023788-19-2
Ntim	25 KG
Txee lub neej	2 xyoo
Cia	Khaws rau hauv qhov chaw txias thiab qhuav
Daim ntawv pov thawj	ISO.